Cell line name |
AML-2-23 |
Accession |
CVCL_D5E7 |
Resource Identification Initiative |
To cite this cell line use: AML-2-23 (RRID:CVCL_D5E7) |
Comments |
Monoclonal antibody isotype: IgG1 (PubMed=6948897); IgG3 (PubMed=2441245). Monoclonal antibody target: UniProtKB; P08571; Human CD14. |
Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) |
Category |
Hybridoma |
Publications | PubMed=6752945; DOI=10.1073/pnas.79.17.5374; PMCID=PMC346899 Edward D. Ball, Robert F. Graziano, Li Shen, Michael W. Fanger; Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity. Proc. Natl. Acad. Sci. U.S.A. 79:5374-5378(1982) PubMed=6948897; DOI=10.4049/jimmunol.128.3.1476 Edward D. Ball, James M. Kadushin, Bernice Zeldin Schacter, Michael W. Fanger; Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells. J. Immunol. 128:1476-1481(1982) PubMed=3894519; DOI=10.4049/jimmunol.135.3.1929 Charles R. Maliszewski, Edward D. Ball, Robert F. Graziano, Michael W. Fanger; Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23. J. Immunol. 135:1929-1936(1985) PubMed=2441245; DOI=10.1016/0161-5890(87)90107-6 Charles R. Maliszewski, Judith Silverstein Currier, Jan Fisher, Robert J. Smith, Michael W. Fanger; Monoclonal antibodies that bind to the My23 human myeloid cell surface molecule: epitope analysis and antigen modulation studies. Mol. Immunol. 24:17-25(1987) |
Cross-references |
Encyclopedic resources |
Wikidata; Q127380230
|
Entry history |
Entry creation | 02-May-2024 |
Last entry update | 10-Sep-2024 |
Version number | 2 |
---|